Avicanna's Shares Jump On $3.2M Export Deal With Brazilian Pharmaceutical Company

Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) finalized a supply agreement with a Brazilian pharmaceutical company via its majority-owned Colombian subsidiary, Santa Marta Golden Hemp S.A.S. Under the three-year master supply agreement, the company will supply industrial volumes of THC and CBD-rich full spectrum psychoactive cannabis resin.

First orders for the pilot batches under the deal are projected to start in . The first orders for commercial batches in 2022 are projected to yield around CA$4 …

Full story available on Benzinga.com

More Avicanna's Shares Jump On $3.2M Export Deal With Brazilian Pharmaceutical Company